(1aR,2S,4aS,8aS)-2,4a,8,8-tetramethyl-1a,3,4,5,6,7-hexahydro-1H-cyclopropa[j]naphthalen-2-ol

Details

Top
Internal ID 3dce4eca-82ca-450b-b7f3-73dea82a67a7
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (1aR,2S,4aS,8aS)-2,4a,8,8-tetramethyl-1a,3,4,5,6,7-hexahydro-1H-cyclopropa[j]naphthalen-2-ol
SMILES (Canonical) CC1(CCCC2(C13CC3C(CC2)(C)O)C)C
SMILES (Isomeric) C[C@@]12CCCC([C@@]13C[C@H]3[C@@](CC2)(C)O)(C)C
InChI InChI=1S/C15H26O/c1-12(2)6-5-7-13(3)8-9-14(4,16)11-10-15(11,12)13/h11,16H,5-10H2,1-4H3/t11-,13-,14-,15-/m0/s1
InChI Key YTLMZAPWDFQBAI-MXAVVETBSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H26O
Molecular Weight 222.37 g/mol
Exact Mass 222.198365449 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 4.00
Atomic LogP (AlogP) 3.75
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1aR,2S,4aS,8aS)-2,4a,8,8-tetramethyl-1a,3,4,5,6,7-hexahydro-1H-cyclopropa[j]naphthalen-2-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9960 99.60%
Caco-2 + 0.8688 86.88%
Blood Brain Barrier + 0.8500 85.00%
Human oral bioavailability + 0.6429 64.29%
Subcellular localzation Lysosomes 0.5298 52.98%
OATP2B1 inhibitior - 0.8440 84.40%
OATP1B1 inhibitior + 0.9139 91.39%
OATP1B3 inhibitior + 0.9550 95.50%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.9049 90.49%
P-glycoprotein inhibitior - 0.9491 94.91%
P-glycoprotein substrate - 0.8802 88.02%
CYP3A4 substrate + 0.5315 53.15%
CYP2C9 substrate + 0.6198 61.98%
CYP2D6 substrate - 0.7380 73.80%
CYP3A4 inhibition - 0.9138 91.38%
CYP2C9 inhibition + 0.5000 50.00%
CYP2C19 inhibition - 0.6875 68.75%
CYP2D6 inhibition - 0.9483 94.83%
CYP1A2 inhibition - 0.5360 53.60%
CYP2C8 inhibition - 0.9580 95.80%
CYP inhibitory promiscuity - 0.9472 94.72%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8500 85.00%
Carcinogenicity (trinary) Non-required 0.6713 67.13%
Eye corrosion - 0.9452 94.52%
Eye irritation + 0.9198 91.98%
Skin irritation + 0.5869 58.69%
Skin corrosion - 0.8791 87.91%
Ames mutagenesis - 0.7900 79.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5251 52.51%
Micronuclear - 0.9300 93.00%
Hepatotoxicity + 0.5085 50.85%
skin sensitisation + 0.5833 58.33%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.6111 61.11%
Mitochondrial toxicity + 0.5125 51.25%
Nephrotoxicity + 0.4845 48.45%
Acute Oral Toxicity (c) III 0.8517 85.17%
Estrogen receptor binding - 0.6972 69.72%
Androgen receptor binding + 0.5721 57.21%
Thyroid receptor binding - 0.6880 68.80%
Glucocorticoid receptor binding - 0.7475 74.75%
Aromatase binding - 0.5577 55.77%
PPAR gamma - 0.7468 74.68%
Honey bee toxicity - 0.9218 92.18%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.5100 51.00%
Fish aquatic toxicity + 0.9260 92.60%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.43% 97.25%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 92.72% 82.69%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.73% 96.09%
CHEMBL240 Q12809 HERG 90.60% 89.76%
CHEMBL206 P03372 Estrogen receptor alpha 89.02% 97.64%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.47% 91.11%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.14% 100.00%
CHEMBL1937 Q92769 Histone deacetylase 2 82.98% 94.75%
CHEMBL259 P32245 Melanocortin receptor 4 82.71% 95.38%

Cross-Links

Top
PubChem 15241194
NPASS NPC217898
LOTUS LTS0170716
wikiData Q105361664